In 2025, the global proteose peptone market is anticipated to be worth USD 151.4 million, with projections indicating a rise ...

and nowhere is this more apparent than in the biopharmaceutical sector. While traditional biotech hubs in the West contend with policy volatility and funding constraints, countries in the Asia ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Find out how efficient Asia’s healthcare system is with Prof Himanshu Rai at the Indian Institute of Management Indore ...

Canadian clinical-stage biotech Zymeworks (Nasdaq: ZYME) today announced that the National Medical Products Administration ...

ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to ...

UK genomics tools developer RevoluGen has signed a distribution agreement with Hong Kong-based life sciences supplier ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

Biotechnology has been in use by humans for ... the previous ban on GMO soybean imports plunged the poultry industry into crisis and reduced consumer purchasing power. Recently, the withdrawal ...